News Square
Global Crypto News · Real-time Aggregation
📚 Deep Analysis
More →GRVT Burns 1.1 Million Tokens as Countdown to Grvt 2.0 Begins
<strong>[PRESS RELEASE – Singapore, Singapore, October 20th, 2026]</strong> <strong>The discretionary buyback represents close to 1% of circulating supply and precedes four planned product milestones culminating in Grvt 2.0.</strong> <a href="https://grvt.io/" rel="nofollow noopener" target="_blank">>Grvt</a>, a self-custodial trading platform built on its own zero-knowledge (ZK) chain, announced that the Foundation’s token issuer has completed its first GRVT token buyback, purchasing and burning 1.1 million GRVT tokens on the open market. The transaction permanently removed close to 1% of GRVT’s circulating supply at the time of purchase. It marks the first of five milestones ahead of the planned launch of Grvt 2.0 at the end of November 2026. <strong>A Discretionary Buyback with On-Chain Verification</strong> The Foundation’s token issuer intends to conduct further buybacks on a monthly basis. Each transaction remains entirely at the issuer’s discretion, with no predetermined purchase amount or guaranteed schedule. Buybacks are executed through an independent execution partner, with purchased tokens transferred to a designated burn address and permanently removed from circulation. The transactions can be independently verified through the <a href="https://grvt.io/exchange/buybacks" rel="nofollow noopener" target="_blank">>public buyback dashboard</a>, which records the number of tokens purchased and burned, the percentage of circulating supply represented, cumulative burns and on-chain transaction hashes. “The GRVT token is an important part of the ecosystem we are building,” said <strong>Hong, co-founder and CEO of Grvt</strong>. “We welcome the issuer’s buybacks as a demonstration of its long-term commitment to the ecosystem and community. Grvt is expanding its products and markets, and the issuer’s buybacks sit alongside that as a supportive mechanism aimed at reducing circulating token supply.” <strong>Grvt Outlines Four Product Milestones</strong> The announcement follows GRVT’s token generation event in July 2026 and precedes a series of planned launches. <strong>Grvt Earn, scheduled for the End of October,</strong> will introduce yield opportunities backed by tokenized assets, with target yields of up to 11%. Potential returns are expected to derive from underlying asset cash flows, including interest, premiums and invoice-related income. Asset-supplying partners will be announced at launch. Target yields are not guaranteed. <strong>Stable Funding Perps, scheduled for November,</strong> will introduce perpetual futures linked to commodities, stocks, foreign exchange and indices. The contracts are planned to carry zero trading fees and use once-daily funding. Grvt aims to list more than 1,000 markets by the end of December 2026. <strong>Yield as Margin, also scheduled for November,</strong> will allow eligible Grvt Earn balances to support trading positions while continuing to accrue yield, subject to applicable product terms
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
OpenAI has bought Orchestra Bio, a San Francisco startup whose AI agents help drug companies keep sprawling development programs on schedule, the ChatGPT maker <a href="https://openai.com/index/openai-to-acquire-orchestra-bio/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>announced Tuesday</a>. “Our goal is to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner,” OpenAI said in the announcement. Orchestra’s team and platform will be folded into <a href="https://openai.com/rosalind/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>Rosalind</a>, OpenAI’s family of AI models and tools for biologists and chemists. The financial terms were not disclosed. Getting a new medicine from first idea to U.S. approval takes time—up to 15 years according to OpenAI. Every month shaved off that timeline is a month earlier that a new treatment can reach the people waiting for it, and a month earlier that the company can generate cash. The process is also absurdly expensive: bringing one approved drug to market can cost more than <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12668846/" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>$2.6 billion</a>, and <a href="https://arxiv.org/pdf/2106.05386" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">fewer than 10%</a> of candidates that enter human testing ever make it to pharmacy shelves. Beyond the science itself, OpenAI says drug teams have to coordinate work across internal departments and outside partners, often relying on systems that don’t talk to each other. Those partners usually include contract research organizations, the outside labs hired to run studies, and contract manufacturers that produce the experimental drug. Orchestra’s AI agents—software that can watch over tasks and flag problems on its own—work out which activities and deadlines take the hit, gather the relevant information and compare ways to respond, while scientists and program leaders make the final call. Founded in the fall of 2022, Orchestra raised its <a href="https://jobs.8vc.com/companies/orchestra/jobs/28818089-senior-software-engineer" target="_blank" rel="nofollow external noopener" class="sc-adb616fe-0 dJryYS">>seed round</a> from Andreessen Horowitz, Definition Capital, Insight Partners, and 8VC, and about $20 million in total, according to <a href="https://www.caplight.com/company/orchestra-bio" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">Caplight data</a>. The company should not be confused with Orchestra BioMed, an unrelated Nasdaq-listed medical device maker that trades under the ticker OBIO. In April, OpenAI launched <a href="https://decrypt.co/364783/openai-gpt-rosalind-drug-discovery-life-sciences-model" target="_blank" class="sc-adb616fe-0 dJryYS" rel="nofollow">GPT-Rosalind</a>, a model built specifically for biology and dru
BTC liquidations over the past 24 hours totaled $58.0144 million.
According to data from Bijie.com, the rolling 24-hour liquidation amount for BTC is approximately 58.0144 million USD, involving about 3,345 liquidated accounts. Compared with the same-caliber snapshot 24 hours earlier, it is up 29.56%; compared with the same-caliber snapshot 7 days earlier, it is up 196.98%.
The Ministry of Foreign Affairs responded to Japan's request for U.S. assistance in persuading China to relax rare earth export controls.
Ministry of Foreign Affairs spokesperson Mao Ning stated at the regular press conference on October 21 that China has implemented export controls on Japan in accordance with laws and regulations, with the aim of stopping Japan's attempts at "remilitarization" and nuclear weapons development. Mao Ning pointed out that China's position of safeguarding the stability and security of global production and supply chains for critical minerals remains unchanged, and all parties have the responsibility to play a constructive role in this regard.
Bitget suspends US stock overnight trading during system upgrade
Bitget has announced that due to an upgrade of Blue Ocean ATS, the upstream exchange system for U.S. stocks, Bitget has temporarily suspended night trading services, affecting U.S. stock spot and U.S. stock Rtoken and related instruments. Pre-market and intraday trading can proceed normally, user assets and underlying funds are unaffected, and unfilled night trading orders are being frozen or canceled according to the rules. Night trading services will automatically resume after the system upgrade is completed.
Zhipu's new model is reported to have up to 3.5 trillion parameters and is expected to reach the level of Claude Fable.
According to a report from Bijie Network, Zhipu's new model is rumored to have up to 3.5 trillion parameters, and is expected to reach the Claude Fable level. A summary of an expert interview circulating in investment communities claims that Zhipu's next-generation foundation model is not the previously rumored 1.6 trillion parameters, but rather 2.5 trillion to 3.5 trillion parameters. The glm-5.3 released by Zhipu in August this year still uses the previous-generation foundation, with a total of approximately 744 billion parameters. If the news is true, the scale of the new foundation will expand to about 3.4 to 4.7 times that of the current version. The summary states that Zhipu adopted a more aggressive model architecture this time, and during pre-training there was a period when the loss did not decrease. The interviewee believes the problem should have been resolved recently, expects training to be completed soon, and predicts that the new model can reach the flagship level of Claude Fable. The new model also aims to solve the "can be released but cannot be supplied" problem after large models are launched. Zhipu has treated inference speed and cost as hard constraints from the architecture design stage, with the goal of being able to operate at large scale on the first day of release, and multiple cloud vendors are already in discussions about revenue sharing.
Ukrainian Prime Minister: Russia's attack targets include Kyiv.
CoinWorld news, Ukrainian Prime Minister: Russian strikes targeted energy facilities in Kyiv, Volyn, Odesa, and Mykolaiv regions.
Japan's Minister of Land, Infrastructure, Transport and Tourism is studying the introduction of a stablecoin refund mechanism.
According to CoinWorld news, Japan's Minister of Land, Infrastructure, Transport and Tourism Tatsunori Ibayashi stated that the government will study the introduction of stablecoins into the consumption tax exemption system for foreign tourists visiting Japan, and will advance efforts to accommodate refund methods. Japan's tax exemption system will switch to a refund method starting November 1, under which tourists purchase goods at tax-inclusive prices and, after leaving the country within 90 days of the purchase date and having it confirmed by customs, receive a refund of the consumption tax from the tax-free store or an entrusted refund institution.
Bank Indonesia Governor: Providing incentives for Non-Deliverable Domestic Forward (DNDF) transactions by offering larger discounts.
Bank Indonesia Governor: Providing incentives for Non-Deliverable Domestic Forward (DNDF) transactions by offering larger discounts.
Injective partners with Korean custodian BDACS to launch the KRW1 stablecoin.
CoinWorld news, according to Cointelegraph: Injective has partnered with South Korean custodian BDACS to use its Korean won-backed KRW1 stablecoin as the exclusive settlement asset for tokenized RWAs on its network.